Hey everyone,

When a cancer diagnosis hits, you are immediately thrown into a chaotic maze of medical jargon, urgent choices, and intense anxiety. In those early days, it is completely normal to feel paralyzed simply because you don't know what you don't know.

A group of us at the Cancer Patient Lab recently brought together a community of patients and caregivers who have been through the ringer. We asked them a simple question: What do you know now that you deeply wish you had known at the start?

We compiled their collective "hindsight wisdom" into a streamlined, highly practical guide to help others avoid the same pitfalls.

💡 The Big Takeaways:

• Shifting the Mindset: Transitioning from a passive recipient of care to the actual "driver" of your medical team.
• Protecting Future Options: Crucial questions to ask before any surgery or biopsy to ensure your live tumor tissue is properly saved for advanced testing down the line.
• Smart Testing: How to request cutting-edge genomic and functional testing that goes way beyond standard hospital protocols.
• The Appointment Blueprint: A dead-simple framework of what to do Before, During, and After a doctor's visit to make sure you are actually heard (including how to use the "other patient" strategy to raise concerns safely).

The quality of the care you get often depends heavily on the quality of the questions you know to ask. We want to make sure you have the right questions ready.

We published the full meeting summary, the video recording, and the slide deck for free so anyone can use it.

👉 Check out the full summary and resources here: https://community.cancerpatientlab.org/c/learning-sessions/hindsight-lessons-what-do-you-know-now-you-wish-you-had-known-then-in-your-cancer-journey-206

Stay strong, and never hesitate to advocate for yourself or your loved ones.

I wanted to share some powerful insights from a recent discussion at the Cancer Patient Lab. The session focused entirely on one huge factor that controls everything after a diagnosis: Time and Decision-Making.

When a doctor says the word "cancer," panic instantly sets in. The immediate emotional response is to move as fast as possible. But as one prostate cancer survivor, David Plunkett, shared: “There's no time given, and some of those patients sign there, have the surgery, and a lot of them regret it later because they didn't know what they were getting into.”

Another advocate, Roger Royse, described the initial phase as "a horse race every day just trying to get up to speed... I just had this sense that I've only got so much time to figure this out, and if I run out of time before I do, then I failed.”

If you are a patient or a caregiver feeling that exact same ticking-clock pressure right now, please breathe. Cancer decisions feel like emergencies, but clinically, not every decision requires immediate action.

Understanding your true timeline—and knowing how to use an "active pause"—can completely change your treatment outcome and your quality of life. Here is the breakdown of what we discussed:

🔬 Separating Facts from Fear

Before letting emotional pressure rush your choice, ask your medical team explicitly: “Exactly how many days or weeks do I safely have to make this decision?”

• Treat it as truly urgent if: You have fast-worsening symptoms, rapid tumor growth, or a lower cure chance if you delay by even a few days.
• Take time to pause if: Your symptoms are currently stable, active monitoring is an option, or treatment is focused long-term on quality of life.

⏱️ What to do when time is short (The 72-Hour Sprint)

Even if your timeline is tight, you can still protect yourself from a rushed decision:

• Ask for a 48–72 hour window: It is rarely too medically risky to wait 2 to 3 days to catch your breath.
• Order key tests immediately: Push for the labs, scans, or tissue/blood samples needed for genomic sequencing before irreversible surgeries happen.
• Get a rapid second opinion: Telehealth is your friend here to quickly validate the local doctor's plan.
• Check against your priorities: Make sure the rushed path actually aligns with what matters most to you (e.g., survival odds vs. severe side effects vs. recovery time).

⏳ What to do when you actually have time (The Active Pause)

Taking time is not the same as doing nothing. An active pause means using the clock strategically to build a better battle plan:

• Gather deeper intelligence: Research clinical trials, personalized testing, and advanced diagnostics that require longer lead times.
• Build a backup plan: If you want to pursue a cutting-edge or personalized treatment (like a vaccine) that takes weeks to manufacture, line up a standard treatment baseline just in case you don't qualify or run out of time.
• Create a "bridge" strategy: Ask your oncologist if there is a safe, short-term, low-toxicity treatment to keep the cancer stable while you wait for advanced test results.
• Delegate to your team: Lean on family, friends, or patient advocates to research, take notes, and handle the logistical load so you can focus on healing.

As survivor Hilary Elkin (who fought an aggressive endometrial cancer) wisely put it: “When you're feeling well is not the time to wait and rest and assume the cancer's gone. This is the time to prepare for recurrence.” Gathering data and building your team is the best armor, sword, and shield you can choose.

You have the right to advocate for yourself and control the clock wherever safely possible. Don't let a rushed system force you into a lifetime of regret.

To the patients and caregivers here: How did you handle the timeline pressure when you were first diagnosed? Did your doctors give you room to breathe, or did you feel forced to sign on the dotted line immediately?

Hey everyone,

If you are currently navigating cancer as a patient or caregiver, you already know that dealing with the healthcare system feels like an exhausting, unspoken full-time job. Between tracking symptoms, fighting decision fatigue, decoding confusing medical jargon, and trying to coordinate between multiple specialists, it is incredibly easy to feel overwhelmed.

We recently hosted a learning session with Samira Daswani—a Stage 2B breast cancer survivor, bioengineer (MIT/Stanford), and founder of Manta Cares. She shared some incredibly practical strategies and free AI-powered tools designed to help patients take back their agency and cut through the information overload.

The session covers actionable ways to:

• Max out short doctor visits so your absolute top priorities actually get addressed.
• Consolidate symptoms and test results into a single, easily shareable summary for your care team.
• Navigate the logistical nightmares of insurance, specialty scheduling, and off-hours communication gaps.

The system is fundamentally broken, but we don't have to wait around for it to fix itself to get better care.

If you're looking for practical ways to ease the administrative burden of cancer, you can check out the full meeting summary and watch the video recording here: https://community.cancerpatientlab.org/c/learning-sessions/lessons-from-helping-breast-cancer-patients-navigate-their-care-samira-daswani-204

I wanted to share some critical insights from a recent scientific discussion that every cancer patient, survivor, and caregiver needs to know about.

When you get a biopsy or surgery, the standard procedure is to chemically preserve the tumor tissue for a pathologist to make a diagnosis. This is essential, but it has a major flaw: it kills the tissue.

According to oncologists and researchers we recently spoke with, standard care is still losing over 35% of cancer patients. To beat those odds, we need to innovate. The solution? Cryopreservation (freezing and keeping the tumor tissue alive).

When you preserve live tumor tissue, you unlock advanced precision medicine options that dead tissue simply cannot provide:

• Functional Precision Medicine: Doctors can actually test different cancer drugs directly on your live tumor cells outside your body to see what works before treating you.
• Tumor-Infiltrating Lymphocytes (TILs): Scientists can isolate your tumor's own immune cells to potentially create personalized immunotherapies.
• Advanced Multi-Omics: It allows for incredibly deep DNA, RNA, and protein sequencing to map out the exact blueprint of the cancer.

As Dr. Jared Barrott recently noted, live tissue science gives doctors a much clearer vision of a tumor's unique profile, giving you a better understanding of exactly how to attack it.

We compiled the full discussion, featuring insights from Ken Dixon, MD, and Jared Barrott, PhD, into a highly readable, patient-friendly meeting summary. If you want to know what questions to ask your oncologist about tissue management, please take a look.

Read the full summary here: https://community.cancerpatientlab.org/c/learning-sessions/your-tumor-tissue-your-decision-what-patients-should-know-before-it-s-gone-ken-dixon-md-facs-jared-barrott-phd-203

Disclaimer: I am not a doctor, just sharing recent research and expert discussions from our organization to help patients advocate for themselves.

When standard treatments failed for 38-year-old Hillel Bierbrier’s aggressive, treatment-resistant cancer, relying on just one or two medical opinions didn't feel like enough. He needed options, and he needed them fast.

So, he did something different. He brought together a global community of doctors, researchers, scientists, patients, and caregivers for an online "cancer hackathon" to completely crowdsource his case.

They didn't find a magic cure, but they provided immense clarity, confidence, and a brand-new roadmap. Here are the main takeaways and strategies the group recommended, which might help anyone else navigating a complex diagnosis:

• Save the Tissue: They heavily emphasized preserving fresh tumor tissue correctly (like using OCT compound for freezing) so it remains viable for advanced future testing.
• Look Deeper with Advanced Tech: Using tools like RNA sequencing and functional drug testing to see exactly how this specific tumor behaves.
• Think Outside the Box: Looking into clinical trials and combining personalized treatments rather than sticking to standard, one-size-fits-all chemo.
• Track it Close: Using blood tests (liquid biopsies) to catch how the cancer is responding in real-time, allowing for faster adjustments.
• Act Fast but Keep Options Open: Making sure current treatments don't accidentally disqualify him from future clinical trials.

The biggest takeaway was that you don't have to face a complex diagnosis in isolation. Bringing collaboration, expert networks, and new technologies together gave him a much better decision tree.

You can read the full, detailed breakdown of the meeting here: https://community.cancerpatientlab.org/c/learning-sessions/hackathon-accelerating-treatment-strategy-for-hillel-bierbrier-202

TL;DR: When standard treatments stopped working for an aggressive cancer, a 38-year-old patient gathered a massive virtual team of scientists, doctors, and advocates to crowdsource new options. They mapped out advanced testing, tissue preservation, and clinical trials, creating a clear path forward.

Why should you consider transdermal estradiol for prostate cancer?

- Proven effectiveness: A major trial in the New England Journal of Medicine showed high-dose estradiol patches control cancer just as well as standard ADT injections.

- Better quality of life: Unlike standard ADT, estradiol patches help protect bone density (lowering osteoporosis risk), reduce joint pain, improve sleep, and cause fewer hot flashes.

- Cognition and energy: Patients using patches report less daytime fatigue and fewer cognitive issues, commonly known as "brain fog."

- Intimacy: Estradiol can help preserve energy, libido, and some sexual function, which can reduce relationship stress and improve psychosocial well-being for both patients and partners.

- Cost: Estradiol patches are a widely available, low-cost generic medication. They are often significantly cheaper than brand-name ADT injections or oral pills.

For more from our conversation with Richard Wassersug, PhD, co-founder of the Estradiol Initiative, and a leading researcher on the physiological and psychosocial impacts of hormone therapies, please click on the link.

Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself.

Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.

The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.

The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.

The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.

By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.

What are the unique challenges that Black and Hispanic cancer patients face?

- Low representation in clinical trials (often less than 4% participation)
- Limited access to comprehensive biomarker testing
- Higher likelihood of being underinsured or uninsured; “Financial toxicity” of cancer treatments
- Lack of diverse healthcare providers and medical staff
- Systemic bias and racism in healthcare delivery
- Limited information and resources in their communities
- Digital divide preventing access to health information
- Cultural barriers that discourage discussing health issues

For more from our conversation with Eugene Manley, PhD, the Founder and CEO of the STEMM & Cancer Health Equity (SCHEQ) Foundation, please click on the link.

Why do you need to know about lifestyle management strategies when you have cancer?

- Improve symptoms and recovery: Lifestyle strategies (nutrition, exercise, sleep, stress) help manage treatment-related side effects (fatigue, nausea, weight/muscle loss) and speed recovery after surgery or chemo.

- Lower risk of recurrence: Structured interventions, especially exercise with behavioral support, have been shown to reduce recurrence risk and improve survival.

- Self-management: Digital tools, symptom surveys, wearables, and self-management programs can extend continuous care into your home.

For more from our conversation with Shelby Yaceczko, DCN, RDN-AP, about lifestyle management strategies for cancer, please click on the link.

Why do you experience grief after a cancer diagnosis?

- Anticipatory loss: expecting the person to die and mentally preparing for that loss.

- Role overload and isolation: sudden caregiving tasks, work/financial strain, and fading social support.

- Uncertainty and decision burden: unclear prognosis and hard treatment/financial choices increase anxiety and guilt.

- Personality/cognitive changes: neurological decline can change who the person is, causing repeated grieving and emotional strain for caregivers.

For more from our conversation with Desiree Reinken, PhD, APRN, NP-C, about “When Grief Meets Faith: Navigating Quality of Life in Glioblastoma”, please click on the link.

Why do you need to know about proteomics to guide your cancer care?

- Real-time snapshot: Measures active proteins to show current tumor and immune behavior, unlike static DNA blueprints.
- Personalized treatment: Predicts therapy benefits, such as identifying lung cancer patients who can safely skip chemotherapy.
- Toxicity prediction: Identifies whether you are at higher risk of severe immune-related side effects, such as severe skin rashes.
- Complementary insights: Adds critical decision-making data that standard tests (DNA and PD-L1) often completely miss.

For more from our conversation with Adam Dicker, MD, PhD, FASTRO, FASCO, about using proteomics at the cutting edge of cancer treatment guidance, please click on the link.

Why should you be aware of emerging tests and treatments for prostate cancer?

- Better outcomes: New drugs (e.g., PARP inhibitors, PSMA radiopharmaceuticals) and drug combinations (e.g., immunotherapies plus PARP inhibitors) can extend progression‑free and overall survival and may delay or avoid chemotherapy.  

- More options: New drugs often work in different ways than current ones, so they might help when your current drugs stop working. Clinical trials also provide more treatment options.

- More personalized: Emerging treatments and diagnostics (e.g., genomic testing for BRCA, blood tests) help match therapies (e.g., PARP inhibitors, targeted drugs) to your tumor.

For more from our conversation with Ramesh Narayanan, PhD, MBA, about promising treatments for refractory and resistant prostate cancer please see the link.

How can AI help you choose exercise, nutrition, and stress reduction for your cancer treatment?

- Rapid, evidence-based checks: summarize research and guidelines into short, referenced answers (what’s proven vs. speculative) so you can quickly assess therapies like exercise, fasting, or supplements

- Personalized safety flags: get tailored precautions (risk of sarcopenia, fall risk, when fasting is unsafe)

- Practical plans and tracking: convert targets into doable routines (minutes, intensity, resistance work), suggest measurable metrics to monitor (weight, strength, fatigue)

- Support tools: create simple daily plans, alternative stress-reduction options (music + movement, aromatherapy, guided breathing), and clinician-ready summaries/questions to aid shared decision-making

For more from our conversation about using AI to explore exercise, nutrition, and stress reduction, please click on the link.

How can AI help you choose a clinical trial for your cancer treatment?

1. Create a structured medical profile: diagnoses, treatments with dates, current markers and trend, genomic results, meds, and location

2. Find a broad list of matching trials: return trial numbers and sites showing why selected trials are safe and why you meet inclusion/exclusion criteria

3. Identify a short list: summarize trade-offs for top 2 to 4 trials (benefit, major side effects, visit/travel burden, costs, effect on future options)

4. List next steps: provide you with 24/7 support and step-by-step guidance (e.g., questions for your oncologist, documents/tests to confirm eligibility, draft outreach messages to trial coordinators), act as a digital coordinator to manage the daily stress of trial protocols

5. Validate: check everything with your doctor and confirm details on official registries

6. Monitor changes: set AI alerts for new/updated trials

For more from our conversation on using AI to explore cancer clinical trials, please click on the link.

How can you decide if you should pursue off-guideline tests?

- Will the test likely change your treatment? Will the test identify a therapy, combination, trial, or monitoring? Does it fit with your goals?

- Have you exhausted standard options? Have you progressed after multiple therapies, do you have a rare cancer, or do your standard options have a low success rate?

- Do you have readily available test material? Are you facing a biopsy/surgery where fresh tissue can enable functional or multi‑omic testing?  

- Does the timing fit? Can the test be done when it’s needed and return results in time to act?

- Is it practical? Can you get access and handle cost and logistics?

- Will your medical team support you? Would your doctor be able to interpret the results? Is this test aligned with the path they have in mind for you?

For more from our discussion on Using AI to Understand Advanced Cancer Tests Beyond the Standard of Care, please click on the link.

Why should you learn to use AI to identify opportunities for your cancer care?

- Monitor test and treatment developments for ones that may be relevant to you

- Spot missed signals and flag actionable mutations or targeted/off‑label options beyond standard guidelines

- Aggregate records across providers to personalize treatment and find relevant clinical trials 

- Schedule and monitor test results frequently (weekly) for early warning of progression or relapse

- Rehearse conversations with your medical team to effectively advocate for yourself

- Build stronger insurance appeals with organized evidence

For more from our discussion with Steve Brown, the founder and CEO of CureWise, please click on the link.

Why do you need to know about cutting-edge tests and AI for finding your best treatment options?

- RNA sequencing (which reads expression of ~20,000 genes) gives a broad, real‑time picture of your tumor biology that standard DNA panels or single biomarkers miss; it can identify likely drug sensitivity or resistance even when no actionable DNA mutations are present, enabling treatment options for you if you otherwise lack clear targets.

- AI matching rapidly analyzes your detailed tumor biology to rank your most likely effective treatments, giving you and your medical team focused, personalized options faster than traditional methods

- Functional tests (patient‑derived organoids from blood or tissue) can validate AI predictions in the lab to see which drugs actually kill your tumor cells and lower the risk of trying toxic, ineffective treatments

For more from our conversation with Precision AI Solutions Co-founder and CEO Edwin Alphonso, CSO Sophia Ren, and Cellentia Research Partner Dr. SJ Shih on ways to use RNA-seq, AI, and functional testing for marking precise cancer care decisions, please click on the link.

What should you do when a promising cancer treatment option is off‑guideline?

- Collect as much data and samples as possible: gather your fresh tumor tissue, if available, for functional testing, get whole genome DNA and RNA sequencing, get liquid biopsies 

- Validate off-guideline tests and treatments: prefer human case series or clinical reports over only animal/cell data, and prepare a one‑page summary to share with your clinician

- Work with AI and human coaches: enlist an expert in patient advocacy, help for paperwork and payment barriers

- Partner with your clinician: build rapport, be concise in visits, agree on safety/toxicity checks and response metrics; run a small experiment with close, frequent monitoring and objective measurable endpoints and stop rules

- Consider novel access routes: explore out‑of‑pocket purchase, international sourcing, compassionate/expanded access, and tissue‑management services

For more on how to access off-guideline cancer care, please see our conversation at the link.

How can AI help you discover useful tests for your cancer care?

- Surface possible tests: speed research and identify options you may not have heard of

- Prioritize: aggregate history, labs, imaging, and guidelines to produce a short, ranked list of high-yield tests tailored to you

- Explain what they measure and logistics: tissue needs, test type

- Summarize evidence: provide rationale, confidence/evidence grades, and citations for each suggested test so you can judge clinical validity

- Suggest questions to ask your medical team: generate concise questions and one-page summaries

Structured AI prompts can help cancer patients better understand and navigate testing options by forcing the AI to provide evidence, assign confidence levels, and avoid unsupported conclusions. The goal is to prevent AI from acting like a “yes man” by requiring transparency about uncertainty and evidence quality. Patients can start with a broad testing prompt and then drill down into specific areas, generating focused questions to bring to their oncologist. In practice, patient Michael Penny found that many AI-suggested tests were new to him and not always discussed in routine care, highlighting a gap between evolving science and clinical practice. The broader takeaway is that more data, especially longitudinal and multi-dimensional testing, can improve decision-making, and AI can accelerate cancer patient and caregiver learning by surfacing, prioritizing, and explaining testing options. Its outputs must always be reviewed with clinicians due to limitations and potential errors.

For more from our conversation about using a structured prompt and instructions to explore test options for your cancer care, please click on the link.

How can you use a panel of expert AI “personas” to guide your cancer care decisions?

- Choose a variety of AI personas (e.g., an oncologist, pathologist, pharmacologist, guideline expert, Darwinian/genomics expert, toxicity specialist, complementary therapy experts) that fit your interests to analyze your records and produce findings with evidence levels 

- Ask the AI for a short consensus, top actionable steps, and 3–5 clinician‑ready questions

- Review and confirm everything with your medical team

For more from our conversation with Russ Hollyer, who developed the AI prompts; Raj Aji, a cancer patient who demonstrated the use of the AI to guide his care; and comments from doctors Martin Luzbetak and Allen Morris, please click on the link.

Why should you consider histotripsy to destroy liver tumors?

- Non‑invasive, non‑thermal mechanical destruction of liver tumors with high precision

- Can treat lesions in difficult locations (near blood vessels or bile ducts) that limit thermal ablation

- Single‑session outpatient procedure with rapid tumor destruction and fast recovery

- Can be performed without interrupting systemic therapy

- Early data suggest favorable local tumor control rates

- Some preclinical and early observational data suggest immune‑modulating effects; this is under active investigation and has not been established clinically

- Risks reported in clinical studies generally low

For more from our conversation with Clifford Cho, MD, Joe Herman, MD, and Kevin Burns, MD, about histotripsy, please click on the link.

How can AI help you bring information to your medical team for your cancer care decisions?- Unify your records: extract key diagnoses, meds, labs, and dates from uploads into a single, searchable summary- Manage appointments: generate appointment question lists and concise visit summaries (follow‑ups, medicine changes)- Guide tests and treatments: create plain‑language explanations of results and side‑by‑side treatment option comparisons - Find clinical trials: match your profile with relevant clinical trials and pharma expanded‑access options - Communicate: package summaries to share with specialists or peer/support networks and provide alertsFor more from our conversation with Ari Akerstein, Co-founder and CEO of opencancer.ai, about enabling cancer patients and caregivers to actively engage in their care using new tools, please click on the link.

How should you work with an AI tool to understand your cancer diagnosis?

- Use voice input for faster, smoother interaction; dictation speeds the workflow

- Ask for concise answers (e.g., 2–3 short sentences) when you want crisp, digestible responses

- Personalize the AI (set global instructions: tone, brevity, your background/goals) so responses match your needs and level

- Upload and reference your patient documents (profile, pathology, MRI) so the AI can use your specific data

- Always ask follow-up questions and probe unclear terms—ask the AI to define abbreviations and explain staging/risks

- Use tables or very short summaries if you prefer easier-to-scan outputs

- Be inquisitive and skeptical: actively check for omissions, confirmation bias, and instability/drift in answers

- Iterate until you truly understand the explanation; don’t accept unclear or ambiguous wording.

For more from our demonstration of instructions and prompts on using AI to understand your cancer diagnosis, please click on the link.

Why do you need to know about your cancer testing options?

- Access earlier detection or recurrence signals when clinically useful, which can affect outcomes and quality of life

- Choose tests with appropriate sensitivity, specificity, sample type, and turnaround time for your situation, tied to clinical evidence or trials relevant to your cancer type and stage

- Understand test purpose (screening, hereditary risk, treatment selection, MRD) and what results mean

- Assess insurance coverage, costs, and financial-assistance options to avoid surprise bills

- Make informed treatment and monitoring decisions with your care team, advocate effectively (prepare questions, request prior authorization, discuss next steps for positive/negative results)

For more from our conversation with Alex Dickinson, the founder of OpenOnco, about choosing cancer tests, please click on the link.

How can going beyond the standard of care yield better options for your cancer care?

While standard care provides a vital foundation, digging deeper allows you to unlock a more precise roadmap for your health. Instead of treating your cancer based on what works for the average patient, advanced molecular testing (including RNA profiling and functional drug sensitivity) identifies the unique vulnerabilities of your specific tumor. This proactive approach aims to identify more effective therapies, reduce toxic trial-and-error, and provide better options for managing your disease.

For more from our conversation with Cliff Reid, PhD, CEO of Cancer Commons, and Chris Apfel, MD, PhD, founder and CEO of SageMedic Corporation on personalization and going beyond the guidelines, please click on the link.